The China Stock to Watch Out For

Larry Kudlow said Thursday evening that a phase one trade deal between China and the U.S. was imminent

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

OPENING VIEW     11/15/2019
Tiny Biotech Scares Big Pharma Unknown Biotech Invents Breakthrough Colon Cancer Treatment New medicine targets patients by their genetic profile. This new discovery threatens Big Pharma companies Pfizer and Astra Zeneca. That makes this small company our #1 Takeover Target for November. Find out the rest of the story here >>>
Kudlow Trade Comments Send Dow Futures Higher By Lillian Currens Share On Renewed trade optimism has Dow futures on the rebound after last night's drop. The blue chip index is signaling an 80-point gain on comments from White House economic advisor Larry Kudlow that the U.S. and China are on the precipice of a trade agreement. Elsewhere, investors are combing over a better-than-forecast 0.3% pop in retail sales for October, just ahead of the holiday shopping season.   Continue reading for more on today's market, including:  How options traders are playing Slack stock ahead of earnings. Why one China tech stock could see even more volatility ahead.  Plus, JCP throws its hat in the earnings ring; Berkshire Hathaway unveils its stake in RH; and J.P. Morgan names Lyft a "top pick."  >> Continue reading...
LATEST HEADLINES
>> Dow Dips with Earnings, Powell in Focus The S&P muscled its way to a record close, though >> JD.Com Stock May See Another Volatile Post-Earnings Swing JD.Com has benefited from long-term support at the 200-day >> Weed Stock Burning Down After Earnings CGC and DDS options volume has ramped up today >> Options Bears Eye More Downside for WORK Stock Before Earnings Options players are targeting December puts today >> Apple Options Run Hot After New "Sell" Rating Maxim also set a $190 price target on AAPL stock Sponsored Tiny Biotech Wins $75 Billion Patent Tiny biotech firm wins $2 billion patent for new treatment that can "Cut & Paste" cancer from your body. The Wall Street Journal reports this breakthrough is "transforming medicine." Our research proves that anyone who gets in by November 25th could turn $1,000 into $1.57 million (or more).
To ensure delivery of Schaeffer's Opening View, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Opening View or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Opening View? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
		SCHAEFFER'S OPENING VIEW enews@schaeffer.com 5151 Pfeiffer Rd. Suite 250 Cincinnati, OH, 45242 USA 800-448-2080 www.schaeffersresearch.com